MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Hu S;Xu Monette ZY;Tzankov A;Green T;Wu L;Balasubramanyam A;Liu WM;Visco C;Li Y;Miranda RN;Montes Moreno S;Dybkaer K;Chiu A;Orazi A;Zu Y;Bhagat G;Richards KL;Hsi ED;Choi WW;Zhao X;van Krieken JH;Huang Q;Huh J;Ai W;PONZONI , MAURILIO;Ferreri AJ;Zhou F;Slack GW;Gascoyne RD;Tu M;Variakojis D;Chen W;Go RS;Piris MA;Møller MB;Medeiros LJ;Young KH

2013-01-01